Wild‐type (WT) Nalm6 cells, a B‐cell precursor leukaemia cell line expressing CD19, and a CD19 KO Nalm6 clone were used to test on‐target cytotoxicity of our CAR‐NK cell products after 14 and 21 days of culture (Figure 5a). The gene discussed is CD19; the disease is leukemia.